NCT06310291 - VTP-1000 in Adults With Celiac Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions

Celiac Disease

Interventions

BIOLOGICAL

VTP-1000

Intramuscular (IM) injection comprised of self-assembling nanoparticles of gluten peptides and a rapamycin component

OTHER

Matched Placebo

Intramuscular (IM) injection comprised of saline solution

Trial Locations (16)

10016

NOT_YET_RECRUITING

NYU Langone - Gastroenterology Associates, New York

21225

RECRUITING

Parexel EPCU Baltimore, Baltimore

23226

RECRUITING

Clinical Research Partners, Richmond

27607

RECRUITING

North Carolina Clinical Research, Raleigh

32216

RECRUITING

Jacksonville Center for Clinical Research, Jacksonville

33705

RECRUITING

GCP Research, St. Petersburg

37232

NOT_YET_RECRUITING

Vanderbilt University Medical Center, Nashville

43213

RECRUITING

Centricity Research, Columbus

48038

RECRUITING

Clinical Research Institute of Michigan, Clinton Township

49159

RECRUITING

West Michigan Clinical Research Center, Wyoming

55905

RECRUITING

Mayo Clinic, Rochester

78744

RECRUITING

PPD Research Unit, Austin

80907

RECRUITING

Peak Gastroenterology Associates, Colorado Springs

84088

RECRUITING

Velocity Clinical Research, Salt Lake City, West Jordan

91206

RECRUITING

Parexel EPCU LA, Los Angeles

98105

RECRUITING

Velocity Clinical Research, Seattle, Seattle